{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:48:09Z","timestamp":1761238089058,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100007077","name":"National Institute of Biomedical Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.bbrc.2014.04.053","type":"journal-article","created":{"date-parts":[[2014,4,19]],"date-time":"2014-04-19T11:49:37Z","timestamp":1397908177000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Resistance to cyclosporin A derives from mutations in hepatitis C virus nonstructural proteins"],"prefix":"10.1016","volume":"448","author":[{"given":"Masaaki","family":"Arai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Tsukiyama-Kohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimi","family":"Tobita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.04.053_b0005","doi-asserted-by":"crossref","first-page":"e82527","DOI":"10.1371\/journal.pone.0082527","article-title":"Isolation and characterization of highly replicable hepatitis C virus genotype 1a strain HCV-RMT","volume":"8","author":"Arai","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2014.04.053_b0010","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1073\/pnas.87.17.6547","article-title":"Hepatitis C virus infection is associated with the development of hepatocellular carcinoma","volume":"87","author":"Saito","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2014.04.053_b0015","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/474S2a","article-title":"Introduction: a smouldering public-health crisis","volume":"474","author":"Gravitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2014.04.053_b0020","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/infdis\/172.4.934","article-title":"Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics","volume":"172","author":"Kohara","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2014.04.053_b0025","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bbrc.2014.04.053_b0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/apt.12546","article-title":"Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort","volume":"39","author":"Backus","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2014.04.053_b0035","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.21809","article-title":"Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B","volume":"46","author":"Fernandes","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2014.04.053_b0040","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/JVI.02614-07","article-title":"Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro","volume":"82","author":"Yang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.053_b0045","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1128\/JVI.00393-11","article-title":"Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner","volume":"85","author":"Foster","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.053_b0050","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/hep.22131","article-title":"The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus","volume":"47","author":"Flisiak","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2014.04.053_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2012.02.024","article-title":"The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection","volume":"57","author":"Hopkins","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2014.04.053_b0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.antiviral.2011.01.003","article-title":"Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy","volume":"89","author":"Lawitz","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbrc.2014.04.053_b0065","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.87.24.9524","article-title":"Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis","volume":"87","author":"Kato","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2014.04.053_b0070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2014.04.053_b0075","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/JVI.02352-08","article-title":"Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus","volume":"83","author":"Love","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.053_b0080","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nature03580","article-title":"Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase","volume":"435","author":"Tellinghuisen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2014.04.053_b0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jmb.2012.04.023","article-title":"Transient structure and SH3 interaction sites in an intrinsically disordered fragment of the hepatitis C virus protein NS5A","volume":"420","author":"Feuerstein","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2014.04.053_b0090","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.bbrc.2009.02.108","article-title":"Domain 3 of non-structural protein 5A from hepatitis C virus is natively unfolded","volume":"381","author":"Hanoulle","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.04.053_b0095","doi-asserted-by":"crossref","first-page":"11550","DOI":"10.1021\/bi700776e","article-title":"Domain 2 of nonstructural protein 5A (NS5A) of hepatitis C virus is natively unfolded","volume":"46","author":"Liang","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2014.04.053_b0100","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1074\/jbc.M111392200","article-title":"Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity","volume":"277","author":"Shirota","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.053_b0105","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1074\/jbc.M809244200","article-title":"Hepatitis C virus NS5A protein is a substrate for the peptidyl-prolyl cis\/trans isomerase activity of cyclophilins A and B","volume":"284","author":"Hanoulle","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.053_b0110","doi-asserted-by":"crossref","first-page":"20441","DOI":"10.1074\/jbc.M110.182436","article-title":"Domain 3 of NS5A protein from the hepatitis C virus has intrinsic alpha-helical propensity and is a substrate of cyclophilin A","volume":"286","author":"Verdegem","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.04.053_b0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jmv.23466","article-title":"Synthetic lipophilic antioxidant BO-653 suppresses HCV replication","volume":"85","author":"Yasui","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbrc.2014.04.053_b0120","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0016-5085(99)70185-X","article-title":"Real-time detection system for quantification of hepatitis C virus genome","volume":"116","author":"Takeuchi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2014.04.053_b0125","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1349-7006.2009.01263.x","article-title":"Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor","volume":"100","author":"Goto","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2014.04.053_b0130","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1128\/AAC.01236-09","article-title":"Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors","volume":"54","author":"Puyang","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2014.04.053_b0135","doi-asserted-by":"crossref","first-page":"e13687","DOI":"10.1371\/journal.pone.0013687","article-title":"DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis\u2013trans isomerisation in domain II of NS5A","volume":"5","author":"Coelmont","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2014.04.053_b0140","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/AAC.00919-12","article-title":"Multiple mutations in hepatitis C virus NS5A domain II are required to confer a significant level of resistance to alisporivir","volume":"56","author":"Garcia-Rivera","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2014.04.053_b0145","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1099\/vir.0.050633-0","article-title":"The C terminus of NS5A domain II is a key determinant of hepatitis C virus genome replication, but is not required for virion assembly and release","volume":"94","author":"Ross-Thriepland","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbrc.2014.04.053_b0150","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1128\/JVI.06641-11","article-title":"A conserved tandem cyclophilin-binding site in hepatitis C virus nonstructural protein 5A regulates Alisporivir susceptibility","volume":"86","author":"Grise","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2014.04.053_b0155","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3390\/v4123303","article-title":"Subtype specific differences in NS5A domain II reveals involvement of proline at position 310 in cyclosporine susceptibility of hepatitis C virus","volume":"4","author":"Ansari","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2014.04.053_b0160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3851\/IMP1667","article-title":"Advances in nucleoside monophosphate prodrugs as anti-HCV agents","volume":"15","author":"Bobeck","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbrc.2014.04.053_b0165","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nature04080","article-title":"Challenges and successes in developing new therapies for hepatitis C","volume":"436","author":"De Francesco","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2014.04.053_b0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.antiviral.2006.06.001","article-title":"Recent development of therapeutics for chronic HCV infection","volume":"71","author":"Huang","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbrc.2014.04.053_b0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.20518","article-title":"Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C","volume":"41","author":"Radkowski","year":"2005","journal-title":"Hepatology"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14006950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14006950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:08:13Z","timestamp":1757761693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14006950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0006291X14006950"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.053","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance to cyclosporin A derives from mutations in hepatitis C virus nonstructural proteins","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}